- Investing.com
Medicover AB (publ) provides healthcare and diagnostic services in Poland, India, Romania, Sweden, and internationally. Its Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. The company’s Diagnostic Services offers laboratory tests in all major clinical pathology areas, ranging from routine to advanced tests and from prevention to monitoring of treatments. Its also comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.
Metrics to compare | MCOVBs | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMCOVBsPeersSector | |
---|---|---|---|---|
P/E Ratio | 175.7x | 20.4x | −0.5x | |
PEG Ratio | −32.42 | 0.12 | 0.00 | |
Price/Book | 6.3x | 1.7x | 2.6x | |
Price / LTM Sales | 1.4x | 0.6x | 2.9x | |
Upside (Analyst Target) | - | 15.7% | 57.2% | |
Fair Value Upside | Unlock | 24.2% | 8.9% | Unlock |